I-MED Pharma USA Announces Michelle Schnabel as VP Business Development
November 09, 2021 11:00 ET
|
I-MED Pharma
MONTREAL, Nov. 09, 2021 (GLOBE NEWSWIRE) -- With the recent expansion into the United States, I-MED Pharma USA is proud to announce the appointment of Michelle Schnabel to the role of VP Business...
I-MED Pharma Celebrates 30 Years of Providing OSD & Surgical Solutions to the Global Eye Care Community
April 01, 2019 10:22 ET
|
I-MED Pharma
MONTREAL, April 01, 2019 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, proudly announces its 30-year anniversary providing OSD &...
I-MED Pharma présente la technologie éprouvée E>Eye IRPL® au Canada
May 24, 2018 13:36 ET
|
I-MED Pharma
MONTRÉAL, 24 mai 2018 (GLOBE NEWSWIRE) -- I-MED Pharma inc., une entreprise canadienne spécialisée dans le diagnostic et la prise en charge de la sécheresse oculaire, est ravie d’annoncer...
I-MED Pharma to Bring Clinically Proven E>Eye IRPL® Technology to Canada
May 24, 2018 13:36 ET
|
I-MED Pharma
MONTREAL, May 24, 2018 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, is pleased to announce the signing of a Canadian distribution...
I-PEN®, I-DROP® et I-LID’N LASH® seront offerts au Danemark, en Suède et en Norvège
October 06, 2017 15:17 ET
|
I-MED Pharma
MONTRÉAL, 06 oct. 2017 (GLOBE NEWSWIRE) -- I-MED Pharma inc., annonce aujourd'hui la nomination de AMWO Farma IVS comme distributeur exclusif du système d'osmolarité lacrymale I-PEN® ainsi que...
I-PEN®, I-DROP® and I-LID’N LASH® will be available in Denmark, Sweden and Norway
October 06, 2017 15:17 ET
|
I-MED Pharma
MONTREAL, Oct. 06, 2017 (GLOBE NEWSWIRE) -- I-MED Pharma, Inc., a Canadian company specialized in dry eye diagnosis and management, announced today the appointment of AMWO Farma IVS as its exclusive...